{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:08:25Z","timestamp":1769605705367,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T00:00:00Z","timestamp":1268179200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-2407-10-90","type":"journal-article","created":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T19:15:37Z","timestamp":1268248537000},"source":"Crossref","is-referenced-by-count":36,"title":["Favourable ten-year overall survival in a Caucasian population with high probability of hereditary breast cancer"],"prefix":"10.1186","volume":"10","author":[{"given":"Laura","family":"Cortesi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Masini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Cirilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Medici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Cavazzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Pasini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Turchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Federico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,10]]},"reference":[{"issue":"5182","key":"1889_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994, 266 (5182): 66-71. 10.1126\/science.7545954.","journal-title":"Science"},{"issue":"6559","key":"1889_CR2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G: Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995, 378 (6559): 789-792. 10.1038\/378789a0.","journal-title":"Nature"},{"issue":"12 Pt 1","key":"1889_CR3","first-page":"2465","volume":"3","author":"WD Foulkes","year":"1997","unstructured":"Foulkes WD, Wong N, Brunet JS, Begin LR, Zhang JC, Martinez JJ, Rozen F, Tonin PN, Narod SA, Karp SE, et al: Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer. Clin Cancer Res. 1997, 3 (12 Pt 1): 2465-2469.","journal-title":"Clin Cancer Res"},{"issue":"24","key":"1889_CR4","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1200\/JCO.2000.18.24.4053","volume":"18","author":"D Stoppa-Lyonnet","year":"2000","unstructured":"Stoppa-Lyonnet D, Ansquer Y, Dreyfus H, Gautier C, Gauthier-Villars M, Bourstyn E, Clough KB, Magdelenat H, Pouillart P, Vincent-Salomon A, et al: Familial invasive breast cancers: worse outcome related to BRCA1 mutations. J Clin Oncol. 2000, 18 (24): 4053-4059.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1889_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1023\/A:1008340723974","volume":"11","author":"WD Foulkes","year":"2000","unstructured":"Foulkes WD, Chappuis PO, Wong N, Brunet JS, Vesprini D, Rozen F, Yuan ZQ, Pollak MN, Kuperstein G, Narod SA, et al: Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome. Ann Oncol. 2000, 11 (3): 307-313. 10.1023\/A:1008340723974.","journal-title":"Ann Oncol"},{"issue":"3","key":"1889_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/cncr.11080","volume":"97","author":"JR Goffin","year":"2003","unstructured":"Goffin JR, Chappuis PO, Begin LR, Wong N, Brunet JS, Hamel N, Paradis AJ, Boyd J, Foulkes WD: Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data. Cancer. 2003, 97 (3): 527-536. 10.1002\/cncr.11080.","journal-title":"Cancer"},{"issue":"1","key":"1889_CR7","first-page":"281","volume":"24","author":"JA Hampl","year":"2004","unstructured":"Hampl JA, Hampl M, Reiss G, Koch R, Saeger HD, Schackert HK: Loss of BRCA2 correlates with reduced long-term survival of sporadic breast cancer patients. Anticancer Res. 2004, 24 (1): 281-290.","journal-title":"Anticancer Res"},{"issue":"2","key":"1889_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJMoa070608","volume":"357","author":"G Rennert","year":"2007","unstructured":"Rennert G, Bisland-Naggan S, Barnett-Griness O, Bar-Joseph N, Zhang S, Rennert HS, Narod SA: Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med. 2007, 357 (2): 115-123. 10.1056\/NEJMoa070608.","journal-title":"N Engl J Med"},{"issue":"2","key":"1889_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/(SICI)1098-2264(200002)27:2<130::AID-GCC3>3.0.CO;2-U","volume":"27","author":"L Cortesi","year":"2000","unstructured":"Cortesi L, Turchetti D, Bertoni C, Bellei R, Mangone L, Vinceti M, Federico M, Silingardi V, Ferrari S: Comparison between genotype and phenotype identifies a high-risk population carrying BRCA1 mutations. Genes Chromosomes Cancer. 2000, 27 (2): 130-135. 10.1002\/(SICI)1098-2264(200002)27:2<130::AID-GCC3>3.0.CO;2-U.","journal-title":"Genes Chromosomes Cancer"},{"issue":"14","key":"1889_CR10","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1038\/sj.onc.1210014","volume":"26","author":"NC Turner","year":"2007","unstructured":"Turner NC, Reis-Filho JS, Russell AM, Springall RJ, Ryder K, Steele D, Savage K, Gillett CE, Schmitt FC, Ashworth A, et al: BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene. 2007, 26 (14): 2126-2132. 10.1038\/sj.onc.1210014.","journal-title":"Oncogene"},{"issue":"43","key":"1889_CR11","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.1038\/sj.onc.1209876","volume":"25","author":"NC Turner","year":"2006","unstructured":"Turner NC, Reis-Filho JS: Basal-like breast cancer and the BRCA1 phenotype. Oncogene. 2006, 25 (43): 5846-5853. 10.1038\/sj.onc.1209876.","journal-title":"Oncogene"},{"issue":"1","key":"1889_CR12","doi-asserted-by":"publisher","first-page":"R8","DOI":"10.1186\/bcr658","volume":"6","author":"ME Robson","year":"2004","unstructured":"Robson ME, Chappuis PO, Satagopan J, Wong N, Boyd J, Goffin JR, Hudis C, Roberge D, Norton L, Begin LR, et al: A combined analysis of outcome following breast cancer: differences in survival based on BRCA1\/BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Res. 2004, 6 (1): R8-R17. 10.1186\/bcr658.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"1889_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10549-006-9288-7","volume":"101","author":"V Bonadona","year":"2007","unstructured":"Bonadona V, Dussart-Moser S, Voirin N, Sinilnikova OM, Mignotte H, Mathevet P, Bremond A, Treilleux I, Martin A, Romestaing P, et al: Prognosis of early-onset breast cancer based on BRCA1\/2 mutation status in a French population-based cohort and review. Breast Cancer Res Treat. 2007, 101 (2): 233-245. 10.1007\/s10549-006-9288-7.","journal-title":"Breast Cancer Res Treat"},{"key":"1889_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/1471-2407-6-210","volume":"6","author":"L Cortesi","year":"2006","unstructured":"Cortesi L, Turchetti D, Marchi I, Fracca A, Canossi B, Battista R, Ruscelli S, Pecchi AR, Torricelli P, Federico M: Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience. BMC Cancer. 2006, 6: 210-10.1186\/1471-2407-6-210.","journal-title":"BMC Cancer"},{"issue":"8","key":"1889_CR15","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/sj.bjc.6600859","volume":"88","author":"P Tassone","year":"2003","unstructured":"Tassone P, Tagliaferri P, Perricelli A, Blotta S, Quaresima B, Martelli ML, Goel A, Barbieri V, Costanzo F, Boland CR, Venuta S: BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells. Br J Cancer. 2003, 88 (8): 1285-91. 10.1038\/sj.bjc.6600859.","journal-title":"Br J Cancer"},{"issue":"31","key":"1889_CR16","doi-asserted-by":"publisher","first-page":"23899","DOI":"10.1074\/jbc.C000276200","volume":"275","author":"A Bhattacharyya","year":"2000","unstructured":"Bhattacharyya A, Ear US, Koller BH, Weichselbaum RR, Bishop DK: The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J Biol Chem. 2000, 275 (31): 23899-23903. 10.1074\/jbc.C000276200.","journal-title":"J Biol Chem"},{"issue":"5","key":"1889_CR17","first-page":"1169","volume":"22","author":"A Fedier","year":"2003","unstructured":"Fedier A, Steiner RA, Schwarz VA, Lenherr L, Haller U, Fink D: The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells. Int J Oncol. 2003, 22 (5): 1169-1173.","journal-title":"Int J Oncol"},{"issue":"12","key":"1889_CR18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S1471-4914(02)02434-6","volume":"8","author":"A Tutt","year":"2002","unstructured":"Tutt A, Ashworth A: The relationship between the roles of BRCA genes in DNA repair and cancer predisposition. Trends Mol Med. 2002, 8 (12): 571-576. 10.1016\/S1471-4914(02)02434-6.","journal-title":"Trends Mol Med"},{"issue":"22","key":"1889_CR19","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1093\/jnci\/djh312","volume":"96","author":"RD Kennedy","year":"2004","unstructured":"Kennedy RD, Quinn JE, Mullan PB, Johnston PG, Harkin DP: The role of BRCA1 in the cellular response to chemotherapy. J Natl Cancer Inst. 2004, 96 (22): 1659-1668.","journal-title":"J Natl Cancer Inst"},{"issue":"53","key":"1889_CR20","doi-asserted-by":"publisher","first-page":"55117","DOI":"10.1074\/jbc.M404524200","volume":"279","author":"M Audebert","year":"2004","unstructured":"Audebert M, Salles B, Calsou P: Involvement of poly(ADP-ribose) polymerase-1 and XRCC1\/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J Biol Chem. 2004, 279 (53): 55117-55126. 10.1074\/jbc.M404524200.","journal-title":"J Biol Chem"},{"issue":"7035","key":"1889_CR21","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, et al: Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature. 2005, 434 (7035): 917-921. 10.1038\/nature03445.","journal-title":"Nature"},{"issue":"8","key":"1889_CR22","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/jmg.39.8.608","volume":"39","author":"PO Chappuis","year":"2002","unstructured":"Chappuis PO, Goffin J, Wong N, Perret C, Ghadirian P, Tonin PN, Foulkes WD: A significant response to neoadjuvant chemotherapy in BRCA1\/2 related breast cancer. J Med Genet. 2002, 39 (8): 608-610. 10.1136\/jmg.39.8.608.","journal-title":"J Med Genet"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-90.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-10-90\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-90","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T06:00:27Z","timestamp":1497852027000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-10-90"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,10]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1889"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-10-90","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,10]]},"article-number":"90"}}